ImageneBio, Inc. Operating Lease, Expense
ImageneBio, Inc. (IMA) reported Operating Lease, Expense of $1.07 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2025-07-24
- ImageneBio, Inc. operating lease, expense for the quarter ending 2025-06-30 was $541.00K, a 17.10% increase year-over-year.
- ImageneBio, Inc. operating lease, expense for the quarter ending 2025-03-31 was $533.00K, a 19.78% increase year-over-year.
- ImageneBio, Inc. operating lease, expense for the quarter ending 2024-12-31 was $525.00K, a 6.58% decline year-over-year.
- ImageneBio, Inc. operating lease, expense for the quarter ending 2024-09-30 was $619.00K, a 31.42% increase year-over-year.
- ImageneBio, Inc. operating lease, expense for fiscal 2024 was $2.05M, a 19.66% increase from fiscal 2023.
- ImageneBio, Inc. operating lease, expense for fiscal 2023 was $1.71M, a 33.59% increase from fiscal 2022.
- ImageneBio, Inc. operating lease, expense for fiscal 2022 was $1.28M, a 9.28% increase from fiscal 2021.
- ImageneBio, Inc. operating lease, expense for fiscal 2021 was $1.17M, a 21.78% increase from fiscal 2020.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $541.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $1.07M 10-Q · filed 2025-07-24 | $1.60M derived: sum of 3 quarters · filed 2025-07-24 | $2.22M derived: sum of 4 quarters · filed 2025-07-24 |
| 2025-03-31 | $533.00K 10-Q · filed 2025-05-08 | $1.06M derived: sum of 2 quarters · filed 2025-05-08 | $1.68M derived: sum of 3 quarters · filed 2025-05-08 | $2.14M derived: sum of 4 quarters · filed 2025-07-24 |
| 2024-12-31 | $525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.14M derived: sum of 2 quarters · filed 2025-03-06 | $1.61M derived: sum of 3 quarters · filed 2025-07-24 | $2.05M 10-K · filed 2025-03-06 |
| 2024-09-30 | $619.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.08M derived: sum of 2 quarters · filed 2025-07-24 | $1.53M 10-Q · filed 2024-11-07 | $2.09M derived: sum of 4 quarters · filed 2025-07-24 |
| 2024-06-30 | $462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $907.00K 10-Q · filed 2025-07-24 | $1.47M derived: sum of 3 quarters · filed 2025-07-24 | $1.94M derived: sum of 4 quarters · filed 2025-07-24 |
| 2024-03-31 | $445.00K 10-Q · filed 2025-05-08 | $1.01M derived: sum of 2 quarters · filed 2025-05-08 | $1.48M derived: sum of 3 quarters · filed 2025-05-08 | $1.82M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.03M derived: sum of 2 quarters · filed 2025-03-06 | $1.38M derived: sum of 3 quarters · filed 2025-03-06 | $1.71M 10-K · filed 2025-03-06 |
| 2023-09-30 | $471.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $815.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.15M 10-Q · filed 2024-11-07 | $1.48M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $344.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $681.00K 10-Q · filed 2024-08-08 | $1.01M derived: sum of 3 quarters · filed 2024-08-08 | $1.34M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $337.00K 10-Q · filed 2024-05-13 | $667.00K derived: sum of 2 quarters · filed 2024-05-13 | $992.00K derived: sum of 3 quarters · filed 2024-05-13 | $1.31M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $655.00K derived: sum of 2 quarters · filed 2024-03-12 | $971.00K derived: sum of 3 quarters · filed 2024-03-12 | $1.28M 10-K · filed 2024-03-12 |
| 2022-09-30 | $325.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $641.00K derived: sum of 2 quarters · filed 2023-11-09 | $953.00K 10-Q · filed 2023-11-09 | $1.26M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $316.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $628.00K 10-Q · filed 2023-08-10 | $934.00K derived: sum of 3 quarters · filed 2023-08-10 | $1.23M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $312.00K 10-Q · filed 2023-05-15 | $618.00K derived: sum of 2 quarters · filed 2023-05-15 | $918.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.21M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $606.00K derived: sum of 2 quarters · filed 2023-03-14 | $901.00K derived: sum of 3 quarters · filed 2023-03-14 | $1.17M 10-K · filed 2023-03-14 |
| 2021-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $595.00K derived: sum of 2 quarters · filed 2022-11-07 | $868.00K 10-Q · filed 2022-11-07 | $1.12M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $568.00K 10-Q · filed 2022-08-11 | $819.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $273.00K 10-Q · filed 2022-05-12 | $524.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $964.00K 10-K · filed 2022-03-17 | ||
| 2020-09-30 | $713.00K 10-Q · filed 2021-11-10 | |||
| 2020-03-31 | $231.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |